| MRI-guided prostate adaptive radiotherapy–A systematic review AJ McPartlin, XA Li, LE Kershaw, U Heide, L Kerkmeijer, C Lawton, ... Radiotherapy and Oncology 119 (3), 371-380, 2016 | 160 | 2016 |
| Reliability and prognostic value of radiomic features are highly dependent on choice of feature extraction platform I Fornacon-Wood, H Mistry, CJ Ackermann, F Blackhall, A McPartlin, ... European radiology 30, 6241-6250, 2020 | 151 | 2020 |
| Long-term outcomes of phase 1 and 2 studies of SBRT for hepatic colorectal metastases A McPartlin, A Swaminath, R Wang, M Pintilie, J Brierley, J Kim, J Ringash, ... International Journal of Radiation Oncology* Biology* Physics 99 (2), 388-395, 2017 | 83 | 2017 |
| Magnetic resonance-based response assessment and dose adaptation in human papilloma virus positive tumors of the oropharynx treated with radiotherapy (MR-ADAPTOR): an R-IDEAL … H Bahig, Y Yuan, ASR Mohamed, KK Brock, SP Ng, J Wang, Y Ding, ... Clinical and translational radiation oncology 13, 19-23, 2018 | 51 | 2018 |
| Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentary AJ McPartlin, NJ Slevin, AJ Sykes, A Rembielak The British Journal of Radiology 87 (1043), 20140501, 2014 | 32 | 2014 |
| Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma L Dixon, S Ramasamy, K Cardale, K Dyker, K Garcez, LW Lee, ... Radiotherapy and Oncology 128 (3), 452-458, 2018 | 27 | 2018 |
| Prospective evaluation of relationships between radiotherapy dose to masticatory apparatus and trismus C Hague, W Beasley, K Garcez, LW Lee, A McPartlin, A McWilliam, ... Acta Oncologica 57 (8), 1038-1042, 2018 | 23 | 2018 |
| Larynx cancer survival model developed through open-source federated learning CR Hansen, G Price, M Field, N Sarup, R Zukauskaite, J Johansen, ... Radiotherapy and Oncology 176, 179-186, 2022 | 20 | 2022 |
| An evaluation of MR based deep learning auto-contouring for planning head and neck radiotherapy C Hague, A McPartlin, LW Lee, C Hughes, D Mullan, W Beasley, A Green, ... Radiotherapy and Oncology 158, 112-117, 2021 | 19 | 2021 |
| Use of a novel atlas for muscles of mastication to reduce inter observer variability in head and neck radiotherapy contouring C Hague, W Beasley, L Dixon, S Gaito, K Garcez, A Green, LW Lee, ... Radiotherapy and Oncology 130, 56-61, 2019 | 17 | 2019 |
| PMH 9907: Long‐term outcomes of a randomized phase 3 study of short‐term bicalutamide hormone therapy and dose‐escalated external‐beam radiation therapy for localized prostate … AJ McPartlin, R Glicksman, M Pintilie, D Tsuji, G Mok, A Bayley, P Chung, ... Cancer 122 (16), 2595-2603, 2016 | 17 | 2016 |
| First-in-human technique translation of oxygen-enhanced MRI to an MR Linac system in patients with head and neck cancer MJ Dubec, DL Buckley, M Berks, A Clough, J Gaffney, A Datta, ... Radiotherapy and Oncology 183, 109592, 2023 | 15 | 2023 |
| Improved accuracy and precision of tracer kinetic parameters by joint fitting to variable flip angle and dynamic contrast enhanced MRI data BR Dickie, A Banerji, LE Kershaw, A McPartlin, A Choudhury, CM West, ... Magnetic resonance in medicine 76 (4), 1270-1281, 2016 | 15 | 2016 |
| High dose rate brachytherapy as a treatment option in endobronchial tumors A Hosni, A Bezjak, A Rink, K Czarnecka, A McPartlin, S Patterson, ... Lung cancer international 2016, 2016 | 15 | 2016 |
| Inter-fraction robustness of intensity-modulated proton therapy in the post-operative treatment of oropharyngeal and oral cavity squamous cell carcinomas C Hague, M Aznar, L Dong, A Fotouhi-Ghiam, LW Lee, T Li, A Lin, ... The British journal of radiology 93 (1107), 20190638, 2020 | 14 | 2020 |
| TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer DJ Thomson, C Cruickshank, H Baines, R Banner, M Beasley, G Betts, ... Clinical and translational radiation oncology 38, 147-154, 2023 | 13 | 2023 |
| Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapy A Barry, A McPartlin, P Lindsay, L Wang, J Brierley, J Kim, J Ringash, ... Practical radiation oncology 7 (5), e331-e337, 2017 | 13 | 2017 |
| Stereotactic body radiotherapy for hepatocellular carcinoma AJ McPartlin, LA Dawson The Cancer Journal 22 (4), 296-301, 2016 | 13 | 2016 |
| Tumor-targeted dose escalation for localized prostate cancer using MR-guided HDR brachytherapy (HDR) or integrated VMAT (IB-VMAT) boost: Dosimetry, toxicity and health related … N Sanmamed, J Lee, A Berlin, T Craig, B Lao, A Rink, A Bayley, C Catton, ... Radiotherapy and Oncology 149, 240-245, 2020 | 12 | 2020 |
| Pretreatment lymphocyte count predicts benefit from concurrent chemotherapy with radiotherapy in oropharyngeal cancer JM Price, HB Mistry, G Betts, EJ Cheadle, L Dixon, K Garcez, T Illidge, ... Journal of Clinical Oncology 40 (20), 2203, 2022 | 11 | 2022 |
